Currently predicting for Thu, 4 Jun 2026

BCAB Prediction Chart

BCAB Predictions History

Latest community submissions for BCAB.
Predictor Target Session Target Price Result Direction Accuracy Score
Oct 17, 2025 $0.780 -97.88% $0.83 X 94.01% 1
Oct 17, 2025 $0.764 -97.93% $0.83 X 92.03% 1
Oct 17, 2025 Bullish $0.83 X 1
Oct 14, 2025 $0.87 -98.09% $0.80 V 91.21% 1
Oct 14, 2025 $0.89 -98.05% $0.80 V 89.39% 1
Oct 14, 2025 Bullish $0.80 X 0
Oct 13, 2025 $0.83 -98.09% $0.91 V 91.17% 0
Oct 13, 2025 $0.84 -98.05% $0.91 V 92.73% 0
Oct 13, 2025 Bullish $0.91 X 1
Oct 9, 2025 $0.88 -98.07% $1.02 V 86.35% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for BCAB with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT BIOATLA, INC.
BioAtla
BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and ovarian cancer. It also develops BA3021, a CAB ADC for multiple solid tumor types, including NSCLC, mel...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE